Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Eagle Pharmaceuticals (EGRX)

Eagle Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EGRX
DateTimeSourceHeadlineSymbolCompany
10/12/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:EGRXEagle Pharmaceuticals Inc
02/12/202421:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
27/11/202421:08Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:EGRXEagle Pharmaceuticals Inc
27/11/202421:08Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:EGRXEagle Pharmaceuticals Inc
27/11/202421:07Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:EGRXEagle Pharmaceuticals Inc
27/11/202421:07Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:EGRXEagle Pharmaceuticals Inc
27/11/202421:07Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:EGRXEagle Pharmaceuticals Inc
27/11/202421:06Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:EGRXEagle Pharmaceuticals Inc
27/11/202421:06Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:EGRXEagle Pharmaceuticals Inc
27/11/202421:05Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:EGRXEagle Pharmaceuticals Inc
27/11/202414:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
26/11/202421:12Edgar (US Regulatory)Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
20/11/202400:59Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:EGRXEagle Pharmaceuticals Inc
14/11/202416:34Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:EGRXEagle Pharmaceuticals Inc
14/11/202415:25Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:EGRXEagle Pharmaceuticals Inc
13/11/202413:30Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:EGRXEagle Pharmaceuticals Inc
12/11/202418:24Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:EGRXEagle Pharmaceuticals Inc
12/11/202412:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
09/10/202420:05Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:EGRXEagle Pharmaceuticals Inc
08/10/202416:42Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:EGRXEagle Pharmaceuticals Inc
02/10/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
27/08/202420:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
09/08/202420:35Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:EGRXEagle Pharmaceuticals Inc
05/08/202413:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
10/07/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
29/05/202412:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
22/05/202413:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
15/05/202413:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
10/05/202421:27Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:EGRXEagle Pharmaceuticals Inc
08/03/202421:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EGRXEagle Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:EGRX